Patent Grant
8147446
A system, device and a method for sustained medical infusion of fluids are described. Some embodiments relate generally to a miniature portable infusion device that can be attached to and detached from a patient's body and that is configured to accurately dispense fluids. Some embodiments relate to a skin securable infusion device that can be periodically disconnected from and reconnected to the body of the patient. Some embodiments relate to a skin securable infusion device that can be disconnected from and reconnected to the body and to a method for detecting whether the infusion device is disconnected or reconnected to the body and for controlling the device's operation accordingly.
Medical treatment of several illnesses requires continuous drug infusion into various body compartments, such as subcutaneous and intra-venous injections. Diabetes mellitus patients, for example, require administration of varying amounts of insulin throughout the day to control their blood glucose levels. In recent years, ambulatory portable insulin infusion pumps have emerged as a superior alternative to multiple daily syringe injections of insulin. These pumps, which deliver insulin at a continuous basal rate as well as in bolus volumes, were developed to liberate patients from repeated self-administered injections, and allow them to maintain a near-normal daily routine. Both basal and bolus volumes must be delivered in precise doses, according to individual prescription, since an overdose or under-dose of insulin could be fatal.
A first generation of portable infusion pumps refers to “pager-like” devices with a reservoir contained within the device's housing. In the first generation devices, a long tube delivers insulin from the pump, which is attached to a belt on the patient, to a remote insertion site. Such devices are disclosed, for example, in U.S. Pat. Nos. 3,771,694, 4,657,486 and 4,498,843. These devices represent a significant improvement over multiple daily injections, but nevertheless, they all suffer from several major drawbacks, among which are the large size and weight of the device, long tubing and lack of discreetness.
To avoid consequences associated with employing a long delivery tube, a new concept was proposed, which was implemented in second generation pumps. The second generation pumps concept relates to a remote controlled skin adherable device with a housing having a bottom surface adapted for contact with the patient's skin, a reservoir disposed within the housing, and an injection needle adapted for communication with the reservoir. This paradigm was described, for example, in U.S. Pat. Nos. 5,957,895, 6,589,229, 6,740,059, 6,723,072 and 6,485,461. The second generation devices also have several limitations: they are bulky, the remote control unit should always be at hand, and they are expensive because the entire device should be discarded every 2-3 days.
Third generation skin adherable devices were devised to avoid the cost issues of the second generation devices and to extend patient customization. An example of such a device was described in the co-owned, co-pending U.S. patent application Ser. No. 11/397,115 and co-owned International Application No. PCT/IL06/001276, the disclosures of which are incorporated herein by reference in their entireties. The third generation devices contain a remote control unit and a skin adherable patch unit (also referred to as a “dispensing patch unit”) that includes two parts: (1) a reusable part containing driving and pumping mechanisms, electronics and other relatively expensive components, and (2) a disposable part containing a reservoir and, in some embodiments, batteries. A tube can also be provided which delivers the fluid from the reservoir to an outlet port that contains a connecting lumen.
This concept can provide a cost-effective skin adherable infusion device and allow diverse usage of the device, such as using it with various reservoir sizes, various needle and cannula types, etc.
In the co-pending, co-owned U.S. patent application Ser. No. 12/004,837, and co-owned International Patent Application No. PCT/IL07/001,578, both filed Dec. 20, 2007, and both claiming priority to U.S. Provisional Patent Application No. 60/876,679, filed Dec. 22, 2006, the disclosures of which are incorporated herein by reference in their entireties, a fourth generation patch unit that can be disconnected from and reconnected to a skin adherable cradle unit was disclosed. In the fourth generation the patch unit, after reservoir filling, is mounted on the body by the following steps:
In the co-pending, co-owned U.S. patent application Ser. No. 11/706,606, the disclosure of which is incorporated herein by reference in its entirety, a device containing a dispensing patch unit (called also “insulin dispensing patch”) and an analyte sensing means (i.e., continuous glucose monitor) was disclosed. This dual function device is configured to have similar configuration to the one outlined above and can also be disconnected from and reconnected to a cradle unit upon patient discretion.
In some conventional systems, although basal delivery should be continuously administered, it is often interrupted due to periodic pump disconnection. In some situations, pump disconnection is mandatory, for example during sauna and hot bath because insulin cannot tolerate high temperatures. However, there are occasions in which a short time disconnection can substantially improve daily activity and patient satisfaction. If the operation of the patch unit's driving mechanism is not suspended prior to disconnection (for example, the user forgets to do so, the disconnection is unintentional, etc.), the patch unit will continue to dispense insulin even though it is not connected to the cradle unit, thus wasting precious insulin and battery power. Moreover, the patient's ability to control the precise amount of delivered insulin will be diminished.
An apparatus and a method for delivering a therapeutic fluid into a body of a patient are provided. In one aspect the device and the method can be implemented using a patch unit removably attachable to a cradle unit, said cradle unit removably attachable to the body of the patient; a position detector comprising a patch portion and a cradle portion, said patch portion coupled to the patch unit, said cradle portion coupled to the cradle unit; a processor adapted for receiving a position indication signal from the at least one position detector, said position indication signal corresponding to a physical proximity of the patch portion to the cradle portion; the processor is further adapted for receiving at least one command from the patient; and, wherein the portable therapeutic device is adapted for at least one therapeutic function selected from the group consisting of delivering a therapeutic fluid into the body of the patient and sensing a bodily analyte.
For example, the patch unit can comprise a reusable part and a disposable part; the disposable part can comprises a reservoir for storing the therapeutic fluid, and, the reusable part can comprise a metering portion for delivering the therapeutic fluid from said reservoir into the body of the patient. The patch unit can be configured to be remotely controlled. In some implementations, the therapeutic fluid can be insulin.
The processor can be adapted to control an operation of the patch unit based on the connection status signal received from the position detector. The processor can further be adapted to control the delivery of the therapeutic fluid into the patient based on the connection status signal. The processor can also be adapted to record commands received from the patient in a memory component. The processor is further adapted to deactivate at least one component of the apparatus based on the connection status signal received from the position detector. The processor can also be configured to initiate a notification to the patient, said notification corresponding to the connection status signal.
In some implementations, the cradle unit can have a cradle base configured as a flat sheet with an adhesive layer facing a skin of the patient and having anchoring means for connection and disconnection of said patch unit; and, a well configured to protrude upwardly from said cradle base to allow alignment and appropriate connection of said patch unit. For example, the well can be adapted for insertion of a cannula into the body of the patient.
In some implementations, the patch unit can be configured to use peristaltic pump to deliver the therapeutic fluid into the body of the patient. It can also be configured to use a piston to deliver the therapeutic fluid to the body of the patient.
In some implementations the position detector can comprise an optical sensor having a light source component and a light detector component. The position detector can also comprise an electro-magnetic detector and/or a magnetic proximity detector.
In another aspect, a method for activating a device for delivering a therapeutic fluid into a body can also be provided. For example, the method can comprise attaching a patch unit to a cradle unit; attaching the cradle unit to the body; generating an activation request for at least one component of at least one of the patch unit and the cradle unit based on a connection status signal generated by a position detector, said position detector comprising a patch portion and a cradle portion, the patch portion coupled to the patch unit, the cradle portion coupled to the cradle unit, said connection status signal corresponding to a physical proximity of the patch portion to the cradle portion.
A device is disclosed that can deliver therapeutic fluid into the body and/or monitor analyte concentration levels. For example, the device can include the following units:
After attaching the cradle unit to the skin, a cannula can be inserted into the subcutaneous compartment of the patient's body through a dedicated passageway (“well”) provided in the cradle unit. During patch-cradle connection, the connecting lumen pierces a self-sealable rubber septum that seals the “well”. Thus, fluid communication is established between the patch unit and the cannula. The patch unit can be connected to and disconnected from the cradle unit upon patient's discretion.
According to some embodiments, the device can be configured to include a position detector configured to detect whether the patch unit is connected to or disconnected from the cradle unit. The position detector, according to some embodiments, includes two parts, one of them being located on the patch unit (“patch portion”) and the other on the cradle unit (“cradle portion”). A central processing unit (“CPU”)/processor can be provided, which receives the position detector's output (connected/disconnected) and controls the patch unit's operation and fluid delivery, accordingly. For example, when the patch is disconnected, fluid delivery can be terminated and after reconnection, it can be resumed.
In some embodiments, the position detector's operation can be based on optical-type detectors or other means. For example, a light emitting diode (“LED”) and a light detector can be adjacently located on the patch unit and the cradle unit can be provided with a reflective surface. Upon disconnection or reconnection, the CPU receives no/yes light inputs from the position detector and accordingly assigns the patch unit a “disconnected” or “connected” position status.
In some embodiments, the position detector is configured to operate as an electronic switch. For example, two conductive surfaces (in some embodiments, the surfaces can be fabricated from gold, nickel, or any other suitable material) can be attached to the lower surface of the patch unit's housing, and a third conductive surface can be attached to the cradle unit. The CPU is configured to assign the patch a certain position status according to whether the patch-cradle conductive surfaces are connected or disconnected (“ON-OFF” state).
Some embodiments include a device that includes a dispensing and/or sensing patch unit that can be disconnected from and reconnected to a skin adherable cradle unit, and that further includes a position detector, while the operation of the device can be controlled according to position detection.
Some embodiments include a device that can includes a miniature patch unit that can be configured to continuously dispense insulin and/or monitor glucose levels, and that further incorporates a position detector, and whose operation can be controlled according to position detection.
Some embodiments include a patch unit that can be disconnected from and reconnected to a cradle unit and enables users to safely disconnect the patch unit for a certain period of time.
Some embodiments include a device that includes a patch unit that can be remotely controlled and can be disconnected from and reconnected to a skin adherable cradle unit and that includes a position detector, and whose operation can be controlled according to position detection.
Some embodiments include a device that includes a patch unit having two parts, e.g., a reusable part and a disposable part, and that can be disconnected from and reconnected to a skin adherable cradle unit, and that further includes a position detector, and whose operation can be controlled according to position detection.
Some embodiments include a device which is miniature, discreet, economical for the users and highly cost effective for the payer, and that incorporates a position detector, and whose operation can be controlled according to position detection.
Some embodiments include a patch unit that continuously monitors body glucose (e.g., blood, ISF) levels and can concomitantly deliver insulin into the body, and that incorporates a position detector, and whose operation can be controlled according to position detection.
Some embodiments include a semi closed-loop system that monitors glucose levels and dispenses insulin according to sensed glucose levels, and incorporates a position detector and operation of the device can be controlled according to position detection.
Some embodiments describe a device that includes a dispensing and/or sensing patch unit (hereinafter, referred to generally as a “patch” or a “patch unit”) that can be disconnected from and reconnected to a skin adherable cradle unit, and that includes a detector device that is configured to detect whether the patch is connected or disconnected (hereinafter, referred to as “position detector”). It is also desirable to provide a method for controlling patch operation according to a position of the patch that has been detected by the position detector.
It is desirable to provide a device that includes a miniature patch that can continuously dispense insulin and/or monitor glucose levels and incorporates a position detector and its operation is controlled according to position detection.
It is also desirable to provide a dispensing patch that can be disconnected from and reconnected to a cradle unit and that enables users to safely disconnect the patch unit for a period of time.
It is desirable to provide a device that contains a patch unit that can be remotely controlled and can be disconnected from and reconnected to a skin adherable cradle unit and that further includes a position detector, whose operation can be controlled according to position detection.
It is desirable to provide a device that contains a patch unit, which includes two parts, e.g., a reusable part and a disposable part, and which can be disconnected from and reconnected to a skin adherable cradle unit, and incorporates a position detector, whose operation can be controlled according to position detection.
It is desirable to provide a device that is miniature, discreet, economical for the users, and cost effective for the payer and that incorporates a position detector, whose operation can be controlled according to position detection.
It is desirable to provide a device that can continuously monitor body glucose (e.g. blood glucose, ISF glucose) levels and concomitantly deliver insulin into the body, and that incorporates a position detector, while the operation of the device can be controlled according to position detection.
It is desirable to provide a device that constitutes a semi closed-loop system that monitors glucose levels and dispenses insulin according to sensed glucose levels, and that incorporates a position detector, while the operation of the device can be controlled according to position detection.
The foregoing and other features, aspects, and advantages of the present invention will be more apparent from the following detailed description, which illustrates exemplary embodiments of the present invention.
a-b illustrate an exemplary device having a patch unit and a remote control unit.
a-b illustrate an exemplary device having a patch unit provided with operating buttons and a display.
a-c illustrate an exemplary cradle unit having a cradle base and a well.
a-d illustrate an exemplary connection of a patch unit to a skin adherable cradle unit.
a-d illustrate exemplary patch units that can be configured to be connected to a skin adherable cradle unit.
a-c illustrate various optional locations of a two-part position detector.
a-c and 9a-b illustrate exemplary optical position detectors.
a-b illustrate an exemplary magnetic position detector.
a-b illustrate an exemplary electro-mechanical position detector.
a-b illustrate an exemplary electronic switch position detector.
a-c are flow charts of exemplary processes following position detector indications or inputted commands.
a-e illustrate an exemplary two-part patch unit provided with manual bolus buttons and a position detector.
a-d illustrate an exemplary two-part patch unit provided with operating buttons, a display and a position detector.
a-b illustrate a device having a patch unit (10) capable of dispensing and/or sensing (hereinafter referred to generally as “patch” or “patch unit”) and a remote control unit (40). In some embodiments, the patch unit (10) can include a single part (
In some embodiments, fluid delivery can be programmed solely by the remote control unit (40) and/or by manual buttons (not shown) which could be provided on the patch unit (10). An embodiment of this arrangement is disclosed in our co-owned International Patent Application No. PCT/IL08/001,001, filed Jul. 20, 2008, claiming priority to U.S. Provisional Patent Application No. 60/961,527, filed Jul. 20, 2007, and titled “Manually Operable Portable Infusion Device”, the disclosures of which are incorporated herein by reference in their entireties.
a-b illustrate another embodiment of the device having a patch unit (10) provided with operating buttons (12) (e.g., keypad) and a display (14). In some embodiments, fluid delivery programming can be carried out by the operating buttons (12). In other embodiments, the device can include also a remote control unit. The patch unit (10) can include a single part (
In some embodiments, the device can include a cradle unit (20) that can be adhered to the skin of the patient, so that the patch unit (10) can be connected to and/or disconnected from the cradle unit (20) as desired. An embodiment of the device employing the cradle unit is disclosed in co-owned U.S. patent application Ser. No. 12/004,837, and International Patent Application No. PCT/IL07/001,578, both filed Dec. 20, 2007, and both claiming priority to U.S. Provisional Patent Application No. 60/876,679, filed Dec. 22, 2006, the disclosures of which are incorporated herein by reference in their entireties.
a-b illustrate side and upper views (respectively) of an exemplary cradle unit (20). The cradle unit (20) can include the following elements:
c illustrates an exemplary embodiment of the cradle unit (20) having a cradle base (300) with anchoring latches (302, 304) and a well (310). Upon attachment of the cradle unit (20) to the patient's skin (5), a cannula (not shown) can be inserted into the subcutaneous compartment of the patient's body through the well (310) of the cradle unit (20). The insertion of the cannula into the subcutaneous compartment can be carried out by a dedicated inserter (not shown), e.g., an embodiment of which is disclosed in a co-owned International Patent Application No. PCT/IL08/000,859 and co-owned, co-pending U.S. patent application Ser. No. 12/215,219, filed Jun. 25, 2008, claiming priority to U.S. Provisional Patent Application No. 60/937,155, entitled “Protector for Cannula and Penetrating Member Insertable in the Body of a Patient”, and filed Jun. 25, 2007, and co-owned International Patent Application No. PCT/IL08/000,860 and co-owned, co-pending U.S. patent application Ser. No. 12/215,255, filed Jun. 25, 2008, claiming priority to U.S. Provisional Patent Application No. 60/937,214, entitled “Insertion Device for Inserting a Cannula into a Body”, and filed Jun. 25, 2007, disclosures of which are incorporated herein by reference in their entireties. Following cannula insertion, a patch unit can be connected to the cradle unit, and fluid delivery and/or analyte sensing can be established.
a illustrates the cradle unit (20) being adhered to the patient's skin (5).
a-d illustrate exemplary patch units that are configured to be attached to the cradle unit (20).
Although basal delivery can be continuously administered to the patient, nevertheless in practice it is often interrupted due to periodic patch unit disconnections, whether mandatory (e.g., during sauna and hot bath), voluntary (e.g., when going to the beach), or accidentally. According to some embodiments, a dedicated position detector can be provided within the device for detecting whether the patch unit is connected or disconnected. For example, the position detector can be configured to generate a signal output, which can be received at the central processing unit (CPU). The position detector's signal output can correspond to the current position status of the patch unit, i.e., whether it is connected to the cradle unit or disconnected therefrom. Upon receiving the output signal, the CPU can assign the patch unit the appropriate position status. Some embodiments implement a method for controlling the patch unit's operation according to the position status of the patch unit assigned by the CPU upon receiving the position detector's signal output.
The position detector according to some embodiments comprises two parts one of which being located on the patch unit (“patch portion”) and the other on the cradle unit (“cradle portion”). It should be borne in mind that according to other embodiments the position detector may comprise only a single part.
a-c illustrate various locations of parts of a position detector (1000) on the cradle unit (20) and on the patch unit (10).
a-c illustrate an embodiment of a position detector that can be configured to use optical sensing. In this embodiment, the position detector can be configured to include a light emitting diode (LED) (112) and a light detector (114). The LED (112) and light detector (114) are configured to be adjacent to the bottom side of the PCB (130) (e.g., the side of the PCB (130) that faces the cradle unit (20)). The LED (112) and the light detector (114) may be separately located items, as shown in
The CPU (140) is configured to receive “yes”/“no” light detection signals, set the patch unit's position status to “connected” or “disconnected” based on the received signal, and control the patch unit's operation accordingly.
The LED (112) can be configured to emit light continuously, periodically (e.g. every 1 sec for a period of 1 μsec), or in any other fashion. This can be done to save energy supplied by at least one battery (240) located in the disposable part (200) or in the reusable part (100).
a-b illustrate another exemplary embodiment of the position detector the operation of which is based on optical sensing, according to the present invention. In this embodiment, the bottom side of the reusable part's (100) housing is configured to have a depression (13). At least two walls (132, 134) of the depression (13) can be fabricated from a transparent material so that light could pass through them. The PCB (130) in this embodiment is configured such that a LED (112) and a light detector (114) can be soldered to the PCB (130) and be situated on opposite sides of the depression (13) thus facing each other. The cradle base (300) is provided with a protrusion (313) configured to fit inside the depression (13) provided in reusable part's (100) housing.
a-b illustrate another exemplary embodiment of the position detector, according to the present invention. A magnetic field applied by a magnet (316), which is provided in the cradle base (300), affects a magnetic component (16), which is attached to the PCB (130). The magnetic component (16) can be any component that is affected by a magnetic field, for example, an electrical “ON/OFF” Reed switch or a Hall Effect sensor with varying voltage output. The signals generated by the magnetic component are interpreted by the CPU (140) as “connected”/“disconnected” positions and the patch's operation is controlled by the CPU (145) accordingly.
a-b illustrate an exemplary embodiment of an electro-mechanical position detector, according to the present invention. In this embodiment, an electronic switch (17) is provided, which can be a commercially available tactile switch (e.g., a tact switch manufactured by Alps Electric Co., Ltd., Japan), or any other electronic switch. The switch can be attached to the PCB (130) and connected to the CPU (140). A portion (117) of the reusable part (100) housing, which is located directly beneath the electronic switch (17), may be fabricated from a resilient material, e.g. rubber, preferably using a dedicated molding process so that the patch unit (10) remains water-tight.
a-b illustrate another exemplary embodiment of the position detector, which can operate as an electronic switch, according to the present invention. In this embodiment, two electrically conductive surfaces (e.g. fabricated from gold or nickel) (18, 19) can be provided in the reusable part's (100) housing. The conductive surfaces (18, 19) are either embedded in the bottom side of the housing of the reusable part (100), or they are secured thereon by any other suitable method. The conductive surfaces (18, 19) can be configured to be electrically connected to the PCB (130) by appropriate wires (180, 190). A third conductive surface (318) can be either embedded in the cradle base (300) or protruding from the cradle base (300). The area of the third conductive surface (318) can be configured to be large enough to ensure that it contacts both conductive surfaces (18, 19) upon connection of the patch unit (10) and the cradle unit (20). The three conductive surfaces (18, 19 and 318) together constitute an electronic switch.
It will be noted, that the switch may alternatively be set up such that establishing contact between the reusable part's conductive surfaces (18, 19) and the cradle base's conductive surface (318), would place the switch in an “OFF” state. In such a case, the CPU will assign the patch unit (10) a “connected” status when the switch is in an “OFF” state and a “disconnected” status when the switch is in an “ON” state.
Another embodiment of the present invention may employ a proximity sensor (e.g. an inductive proximity sensor) as a position detector. In case an inductive proximity sensor is employed, the sensor is attached to the PCB, and the cradle base can be provided with a surface fabricated from a magnetic material (e.g., ferromagnetic material), which could be either embedded in the cradle base or protruding from it. The sensor can use a coil or an inductor as a transducer to produce a magnetic field. When the patch unit is in close proximity to the cradle unit, the magnetic surface would be exposed to the sensor's magnetic field. Electrical currents (i.e., Eddy currents) would then build up in the magnetic surface and dampen the sensor's magnetic field. Changes in the magnetic field would result in changes in the sensor's signal output sent to the CPU, and the patch unit's status would be set accordingly. An output threshold can be preprogrammed such that the CPU will set the patch unit's status to “connected” only when the distance between the sensor and the magnetic surface is at its minimum corresponding to a situation when the patch unit is connected to the cradle unit.
Some steps may be carried out automatically when the patch unit's position is changed. Such steps may include, for example, deactivation or activation (706, 707) of the patch unit's driving mechanism (146) and deactivation or activation of one or more sensing apparatuses (147), as will be demonstrated below. The sensing apparatus (147) can be, for example, a sensor for detecting occlusion in the fluid delivery tube, as described in co-pending, co-owned U.S. patent application Ser. No. 11/810,854 and co-owned International Patent Application No. PCT/IL07/000,684, both filed Jun. 6, 2007, disclosures of which are incorporated herein by reference in their entireties. Other sensing apparatuses may include a sensor for monitoring analyte (e.g., glucose) concentration levels in the patient's body, as disclosed, for example, in co-pending, co-owned U.S. patent application Ser. No. 11/706,606, filed Feb. 14, 2007, disclosure of which is incorporated herein by reference in its entirety.
A notification (as shown in step 705) may be sent to the user via an indication means (145) (e.g. buzzer, visual display) upon position status change and upon activation/deactivation of a patch unit component based on a position status change. The current position (designated by numeral 702′ in
a is a flow chart of an exemplary process (730) that takes place after command (701) is received by the CPU. The command (701) is checked (as shown in step 732) in accordance to a current patch position. If the command can be executed, then the execution can be immediately performed (as shown in step 733). If the command cannot be executed, then it can be stored (as shown in step 734) for a later execution. The user can be notified accordingly, as shown in step 735. For example, a bolus delivery command can be received while the patch unit's current status (702′) is “disconnected”. The command cannot be executed and thus it is stored for a later execution, i.e., upon reconnection of the patch unit to the cradle unit. Appropriate notification can be sent to the patient.
The execution of some commands does not depend on the patch unit's status, i.e., the command can be executed whether the patch is connected or disconnected. An example of such a command is a “set clock” command, which sets the clock of the patch unit according to user input. Some inexecutable commands are not stored for later execution but they are cancelled once they are determined “inexecutable”, e.g., a periodical command to sample the occlusion sensor.
b is a flow chart of an exemplary process (750) taking place after receiving position indication (702) from the patch portion of the position indicator (143). If there is a mismatch (as shown in step 751) between the received position (702) and the current position (702′), the following exemplary steps can be carried out in any suitable order:
Step 752: update current position (702′);
Step 753: activate or deactivate patch components based on the current position (702′);
Step 754: store relevant data (e.g., position change timing);
Step 755: process and execute previously stored commands (701′) (e.g., using process 730) according to patch position.
When the patch unit is being disconnected from the cradle unit its position is set to “disconnected” status, the driving mechanism can be deactivated, and timing and amount of undelivered volume can be recorded. If the patch unit is provided with operating buttons and a display, the operating buttons may be unlocked and the display may be activated upon disconnection. After reconnection the patch position can be set to “connected” status, timing is recorded, fluid delivery is resumed, the operating buttons may become locked, and the display may be deactivated.
c is a flow chart of an exemplary process (760) for position checking after every command (701) is received. The following exemplary steps can be performed by process (760) in any suitable order:
Step 761: send a position status request (704) from the CPU to the position detector, and receive position status indication (702);
Step 762: check command (701) in accordance with received patch position status (702),
Step 763: execute the command if it is executable;
Step 764: store the command if it is inexecutable;
Step 765: notify the patient.
In some embodiments, a bolus delivery command generated by the user can be received at the CPU, and a “disconnected” position status indication (702) can be generated by the position detector. The command cannot be executed, it is therefore stored for later execution, and notification (as shown in step 765) can be sent to the patient. Some inexecutable commands are not stored for a later execution but they are cancelled once they are determined “inexecutable”, e.g., a periodical command to sample the occlusion sensor.
As explained above, various position detectors can allow the user to safely disconnect and reconnect the patch unit from and to the cradle unit without using the remote control for suspension or resumption of patch operation, because these actions can be done automatically upon disconnection/reconnection of the patch unit to the cradle unit. The position detector can also prevent the patch unit from operating in case of unintentional disconnection.
A co-owned International Patent Application No. PCT/IL08/001,001, filed Jul. 20, 2008, claiming priority to U.S. Provisional Patent Application No. 60/961,527, filed Jul. 20, 2007, and titled “Manually Operable Portable Infusion Pump” discloses a patch unit having manual button(s) allowing the user to initiate bolus delivery without using the remote control unit. In some embodiments, a dedicated position detector for detecting whether the patch unit is connected to or disconnected from the cradle unit can be used. In other embodiments, a method for controlling the patch unit's operation accordingly can be implemented.
One of the advantages of using some implementations of the detector can be that the user can press the bolus button(s) in a situation when the patch unit is disconnected from the cradle unit and bolus delivery will commence only after the patch unit has been reconnected to the cradle unit.
a-d illustrate an exemplary two-part patch unit (10) provided with manual buttons (15) and with a position detector (not shown in the Figures).
A co-owned International Patent Application No. PCT/IL08/001,057, entitled “Portable Infusion Device with Means for Monitoring and Controlling Fluid Delivery”, filed Jul. 31, 2008, claiming priority to U.S. Provisional Patent Applications No. 60/963,148, filed on Aug. 1, 2007, and No. 61/004,019, filed on Nov. 21, 2007, both entitled “Portable Infusion Device with Means for Monitoring and Controlling Fluid Delivery”, discloses an exemplary embodiment of a patch unit provided with operating buttons and a display which allow the user to control all aspects of both basal and bolus delivery, as well as analyte monitoring in some embodiments, directly from the patch unit without use of a remote control unit.
a-d illustrate an exemplary two-part patch unit (10) provided with operating buttons (the buttons are designated as a group by numeral 12), a display (14) and a position detector (not seen). In this embodiment the user can disconnect the patch unit (10) from the cradle unit (20), issue the necessary fluid delivery and/or sensing commands using the operating buttons (12) and the display (14), and then reconnect the patch unit (10). In some implementations, the programmed commands can be executed only after the patch unit (10) is reconnected to the cradle unit (20).
Various implementations of the subject matter described herein may be realized in digital electronic circuitry, integrated circuitry, specially designed ASICs (application specific integrated circuits), computer hardware, firmware, software, and/or combinations thereof. These various implementations may include implementation in one or more computer programs that are executable and/or interpretable on a programmable system including at least one programmable processor, which may be special or general purpose, coupled to receive data and instructions from, and to transmit data and instructions to, a storage system, at least one input device, and at least one output device.
These computer programs (also known as programs, software, software applications or code) include machine instructions for a programmable processor, and may be implemented in a high-level procedural and/or object-oriented programming language, and/or in assembly/machine language. As used herein, the term “machine-readable medium” refers to any computer program product, apparatus and/or device (e.g., magnetic discs, optical disks, memory, Programmable Logic Devices (PLDs)) used to provide machine instructions and/or data to a programmable processor, including a machine-readable medium that receives machine instructions as a machine-readable signal. The term “machine-readable signal” refers to any signal used to provide machine instructions and/or data to a programmable processor.
To provide for interaction with a user, the subject matter described herein may be implemented on a computer having a display device (e.g., a CRT (cathode ray tube) or LCD (liquid crystal display) monitor) for displaying information to the user and a keyboard and a pointing device (e.g., a mouse or a trackball) by which the user may provide input to the computer. Other kinds of devices may be used to provide for interaction with a user as well; for example, feedback provided to the user may be any form of sensory feedback (e.g., visual feedback, auditory feedback, or tactile feedback); and input from the user may be received in any form, including acoustic, speech, or tactile input.
The subject matter described herein may be implemented in a computing system that includes a back-end component (e.g., as a data server), or that includes a middleware component (e.g., an application server), or that includes a front-end component (e.g., a client computer having a graphical user interface or a Web browser through which a user may interact with an implementation of the subject matter described herein), or any combination of such back-end, middleware, or front-end components. The components of the system may be interconnected by any form or medium of digital data communication (e.g., a communication network). Examples of communication networks include a local area network (“LAN”), a wide area network (“WAN”), and the Internet.
The computing system may include clients and servers. A client and server are generally remote from each other and typically interact through a communication network. The relationship of client and server arises by virtue of computer programs running on the respective computers and having a client-server relationship to each other.
Although particular embodiments have been disclosed herein in detail, this has been done by way of example for purposes of illustration only, and is not intended to be limiting with respect to the scope of the appended claims, which follow. In particular, it is contemplated that various substitutions, alterations, and modifications may be made without departing from the spirit and scope of the invention as defined by the claims. Other aspects, advantages, and modifications are considered to be within the scope of the following claims. The claims presented are representative of the inventions disclosed herein. Other, unclaimed inventions are also contemplated. The applicant reserves the right to pursue such inventions in later claims.
Any and all of the foregoing patents, applications, and publications referenced in this specification are hereby incorporated by reference herein in their entireties.
The present application claims priority to and is a 35 U.S.C. §371 national stage entry of PCT/IL2008/001056, having an international filing date of Jul. 31, 2008 and claiming priority to U.S. Provisional Patent Application No. 60/963,045, filed on Aug. 1, 2007 and 60/999,654, filed on Oct. 19, 2007. The present application incorporates herein by reference the disclosures of each of the above-referenced applications in their entireties.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/IL2008/001056 | 7/31/2008 | WO | 00 | 1/29/2010 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2009/016635 | 2/5/2009 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 3771694 | Kaminski | Nov 1973 | A |
| 4498843 | Schneider et al. | Feb 1985 | A |
| 4657486 | Stempfle et al. | Apr 1987 | A |
| 5957895 | Sage et al. | Sep 1999 | A |
| 6485461 | Mason et al. | Nov 2002 | B1 |
| 6589229 | Connelly et al. | Jul 2003 | B1 |
| 6723072 | Flaherty et al. | Apr 2004 | B2 |
| 6740059 | Flaherty | May 2004 | B2 |
| 6749587 | Flaherty | Jun 2004 | B2 |
| 20020169439 | Flaherty | Nov 2002 | A1 |
| 20030088238 | Poulsen et al. | May 2003 | A1 |
| 20070106218 | Yodfat et al. | May 2007 | A1 |
| 20070191702 | Yodfat et al. | Aug 2007 | A1 |
| 20080021395 | Yodfat et al. | Jan 2008 | A1 |
| 20080077081 | Mounce et al. | Mar 2008 | A1 |
| 20080215035 | Yodfat et al. | Sep 2008 | A1 |
| 20080319414 | Yodfat et al. | Dec 2008 | A1 |
| 20080319416 | Yodfat et al. | Dec 2008 | A1 |
| Number | Date | Country |
|---|---|---|
| WO 2006097453 | Sep 2006 | WO |
| WO 2007056504 | May 2007 | WO |
| WO 2007071255 | Jun 2007 | WO |
| WO 2008029403 | Mar 2008 | WO |
| WO 2008038274 | Apr 2008 | WO |
| WO 2008139458 | Nov 2008 | WO |
| WO 2009013736 | Jan 2009 | WO |
| WO 2009016636 | Feb 2009 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20100137790 A1 | Jun 2010 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60963045 | Aug 2007 | US | |
| 60999654 | Oct 2007 | US |
